Kurt RA - Search Results

1

Chemokine receptor desensitization in tumor-bearing mice.

Kurt RA, Baher A, Wisner KP, Tackitt S, Urba WJ. Kurt RA, et al. Cell Immunol. 2001 Feb 1;207(2):81-8. doi: 10.1006/cimm.2000.1754. Cell Immunol. 2001. PMID: 11243697

2

Peripheral T lymphocytes from women with breast cancer exhibit abnormal protein expression of several signaling molecules.

Kurt RA, Urba WJ, Smith JW, Schoof DD. Kurt RA, et al. Int J Cancer. 1998 Sep 25;78(1):16-20. doi: 10.1002/(sici)1097-0215(19980925)78:1<16::aid-ijc4>3.0.co;2-#. Int J Cancer. 1998. PMID: 9724088

3

Mutated cytochrome b as a determinant of a new monoclonal antibody (H8.98) on renal carcinoma cell lines recognized by a Vgamma3Vdelta1(+) T-cell clone.

Choudhary A, Kurt RA, Goret F, Moreau A, Diéz E, Urba WJ, Jotereau F, Pourcel C. Choudhary A, et al. Among authors: kurt ra. Int J Cancer. 1999 Aug 12;82(4):562-8. doi: 10.1002/(sici)1097-0215(19990812)82:4<562::aid-ijc15>3.0.co;2-w. Int J Cancer. 1999. PMID: 10404071

4

Isolation of genes overexpressed in freshly isolated breast cancer specimens.

Kurt RA, Urba WJ, Schoof DD. Kurt RA, et al. Breast Cancer Res Treat. 2000 Jan;59(1):41-8. doi: 10.1023/a:1006315919985. Breast Cancer Res Treat. 2000. PMID: 10752678

5

TCR v(beta) usage and clonality of T cells isolated from progressing and rejected tumor sites before and after in vitro culture.

Kurt RA, Park JA, Schluter SF, Marchalonis JJ, Akporiaye ET. Kurt RA, et al. Int Immunol. 2000 May;12(5):639-46. doi: 10.1093/intimm/12.5.639. Int Immunol. 2000. PMID: 10784610

6

Spontaneous mammary carcinomas fail to induce an immune response in syngeneic FVBN202 neu transgenic mice.

Kurt RA, Whitaker R, Baher A, Seung S, Urba WJ. Kurt RA, et al. Int J Cancer. 2000 Sep 1;87(5):688-94. Int J Cancer. 2000. PMID: 10925363

7

Role of C chemokine lymphotactin in mediating recruitment of antigen-specific CD62L(lo) cells in vitro and in vivo.

Kurt RA, Bauck M, Harma S, McCulloch K, Baher A, Urba WJ. Kurt RA, et al. Cell Immunol. 2001 May 1;209(2):83-8. doi: 10.1006/cimm.2001.1790. Cell Immunol. 2001. PMID: 11446740

8

Regression of a mammary adenocarcinoma in STAT6-/- mice is dependent on the presence of STAT6-reactive T cells.

Jensen SM, Meijer SL, Kurt RA, Urba WJ, Hu HM, Fox BA. Jensen SM, et al. Among authors: kurt ra. J Immunol. 2003 Feb 15;170(4):2014-21. doi: 10.4049/jimmunol.170.4.2014. J Immunol. 2003. PMID: 12574371

9

Altered chemokine receptor sensitivity in FVBN202 rat neu transgenic mice.

Kurt RA, Bauck M, Harma S, Adler E, Vitiello P, Wisner KP, Tackitt S, Urba WJ. Kurt RA, et al. Breast Cancer Res Treat. 2003 Feb;77(3):225-32. doi: 10.1023/a:1021853202515. Breast Cancer Res Treat. 2003. PMID: 12602922

10

Immune effects of escalating doses of granulocyte-macrophage colony-stimulating factor added to a fixed, low-dose, inpatient interleukin-2 regimen: a randomized phase I trial in patients with metastatic melanoma and renal cell carcinoma.

Smith II JW, Kurt RA, Baher AG, Denman S, Justice L, Doran T, Gilbert M, Alvord WG, Urba WJ. Smith II JW, et al. Among authors: kurt ra. J Immunother. 2003 Mar-Apr;26(2):130-8. doi: 10.1097/00002371-200303000-00005. J Immunother. 2003. PMID: 12616104 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

62 results

Search Page

Filters